Lung cancer is the leading cause of cancer-related death worldwide with an incidence in the Netherlands of 300 new patients per 100,000 inhabitants in 2011. The prognosis remains poor with a 5-year overall survival of only 16%. Non-small cell lung cancer (NSCLC) accounts for 85% of the cases and 70% per cent of these are locally advanced or metastasized at the time of diagnoses. Wilma Uijterlinde focuses on the toxicity induced by (concurrent) chemo-radiotherapy for locally advanced non-small cell lung cancer. Her aim is to study predictive parameters for toxicity and to quantify acute and late toxicity as well as to investigate supportive care management options for the improvement of treatment adherence.
W.I. Uijterlinde, Prediction of Toxicity in Concurrent Chemoradiation for Non-Small Cell Lung Cancer.
Prof. P. Baas
Prof. M. Verheij (NKI-AVL)
Dr M.M. van der Heuvel (NKI-AVL)
This event is open to the public.